Hunan Dajiaweikang Pharmaceutical Industry Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 6.49% vs 1.51% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -3.77% vs -52.04% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,384.20",
          "val2": "1,299.80",
          "chgp": "6.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.20",
          "val2": "65.80",
          "chgp": "-60.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "21.90",
          "val2": "25.40",
          "chgp": "-13.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.20",
          "val2": "10.60",
          "chgp": "-3.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.00%",
          "val2": "19.80%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 34.02% vs 18.58% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 35.00% vs -31.28% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,222.50",
          "val2": "3,896.90",
          "chgp": "34.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "363.40",
          "val2": "221.10",
          "chgp": "64.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "114.10",
          "val2": "80.20",
          "chgp": "42.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-12.70",
          "val2": "-0.50",
          "chgp": "-2,440.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "51.30",
          "val2": "38.00",
          "chgp": "35.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.20%",
          "val2": "31.20%",
          "chgp": "0.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

1,384.20

1,299.80

6.49%

Operating Profit (PBDIT) excl Other Income

26.20

65.80

-60.18%

Interest

21.90

25.40

-13.78%

Exceptional Items

0.00

0.00

Consolidate Net Profit

10.20

10.60

-3.77%

Operating Profit Margin (Excl OI)

19.00%

19.80%

-0.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 6.49% vs 1.51% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -3.77% vs -52.04% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

5,222.50

3,896.90

34.02%

Operating Profit (PBDIT) excl Other Income

363.40

221.10

64.36%

Interest

114.10

80.20

42.27%

Exceptional Items

-12.70

-0.50

-2,440.00%

Consolidate Net Profit

51.30

38.00

35.00%

Operating Profit Margin (Excl OI)

37.20%

31.20%

0.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 34.02% vs 18.58% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 35.00% vs -31.28% in Dec 2023

All Annual Results